comparemela.com

Latest Breaking News On - Rad laboratories trading down - Page 3 : comparemela.com

Bio-Rad Laboratories (NYSE:BIO) Posts Earnings Results, Misses Estimates By $0 54 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) announced its quarterly earnings results on Thursday. The medical research company reported $2.33 EPS for the quarter, missing the consensus estimate of $2.87 by ($0.54), Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 5.86% and a positive return on equity of 3.82%. The firm had revenue […]

Tobam Takes $57,000 Position in Bio-Rad Laboratories, Inc (NYSE:BIO)

Tobam acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 150 shares of the medical research company’s stock, valued at approximately $57,000. A number of other institutional investors also […]

Tamarack Advisers LP Invests $479,000 in Bio-Rad Laboratories, Inc (NYSE:BIO)

Tamarack Advisers LP Invests $479,000 in Bio-Rad Laboratories, Inc (NYSE:BIO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Bio-Rad Laboratories (NYSE:BIO) Posts Earnings Results, Beats Estimates By $0 45 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 7.01% and a positive return on equity of 4.10%. The business […]

Bio-Rad Laboratories (NYSE:BIO) Issues Earnings Results, Beats Expectations By $0 45 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) announced its quarterly earnings data on Thursday. The medical research company reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. The company had revenue of $681.10 million for the quarter, compared to analyst estimates of $697.96 million. Bio-Rad Laboratories […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.